Commercial launch of BIOCERA-VET Bone Surgery Ready-to-Use, BIOCERA-VET Granules, BIOCERA-VET Smartgraft and BIOCERA-VET Osteosarcoma Ready-To-Use in Belgium, France, Netherlands, United Kingdom
Exclusive distribution agreement for the whole new BIOCERA-VET line in Spain Nuzoa's sales force in support of commercialization Commercial launch earlier than anticipated Regulatory
Distribution agreement for the new BIOCERA-VET® product line including Bone Surgery - Ready to Use, Osteosarcoma Ready to Use, Granules & Smartgraft - in United Kingdom and IrelandKey marketing and sales support for the upcoming commercial launch of these products in United Kingdom and IrelandGOSSELIES, Wallonia, Be.
Positive safety and efficacy results for BIOCERA-VET (arthrodesis and canine osteosarcoma) and VISCO-VET (canine osteoarthritis) Initiation of the pivotal European multicentric clinical study
Positive safety and efficacy results for BIOCERA-VET® (arthrodesis and canine osteosarcoma) and VISCO-VET® (canine osteoarthritis)Initiation of the pivotal European multicentric clinical study evaluating VISCO-VET® in canine osteoarthritisCommercialization of BIOCERA-VET® Bone Surgery and BIOCERA-VET® Osteosarcoma i.